Tune Therapeutics
Tune Therapeutics develops TEMPO, an epigenomic platform that fine-tunes gene activity without altering DNA. It is developing therapies for chronic hepatitis B, rare single-gene disorders and other conditions.
Facts
- HQ
- Seattle, Washington, USA and Durham, North Carolina, USA
- Sectors
- Biotechnology, Therapeutics, Epigenomics
- Stage
- Series B
- Members see funding amounts. .
Is this your organization? Claim it
Blue Origin's New Glenn Rocket Achieves First Orbital Launch Amid Schedule Hiccups; Microsoft Creates New AI Division Led by Ex-Facebook Chief; Truveta Raises $320M for Genome Initiative
Jeff Bezos' Blue Origin faced multiple scheduling changes before successfully launching its heavy-lift New Glenn rocket to orbit for the first time. Additionally, Microsoft established a new AI division led by a former Facebook engineering chief, and Seattle's Truveta secured $320 million to start a large genome project.
Seattle Immunotherapy Startup Umoja Biopharma Raises $100M Series C to Advance In Vivo CAR T-Cell Cancer Therapies
Seattle-based Umoja Biopharma raised $100 million in a Series C funding round to advance its CAR T-cell immunotherapy treatments, including an in vivo cell-generating technology for cancer. The company, founded in 2019 and led by CEO Andy Scharenberg, has programs in preclinical and Phase 1 stages and previously raised $263 million.
Seattle Biotech Tune Therapeutics Raises $175M to Advance Epigenetic Editing Trials for Chronic Hepatitis B
Seattle-based biotech startup Tune Therapeutics raised $175 million to support clinical trials of its epigenetic editing treatments for chronic Hepatitis B. The funding will aid development of therapies that control gene expression without altering DNA, leveraging technology developed at Duke University.
Questions about Tune Therapeutics
What is Tune Therapeutics?
Seattle, Washington, USA and Durham, North Carolina, USA
Who invested in Tune Therapeutics, and how much has it raised?
Members of Seattle Flow see Tune Therapeutics' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is Tune Therapeutics based?
Tune Therapeutics is headquartered in Seattle, Washington, USA and Durham, North Carolina, USA.